Lapatinib Induced Suicidal Death of Human Erythrocytes
Background/Aims: The human epidermal growth factor receptors tyrosine kinase inhibitor lapatinib has been shown to trigger suicidal death or apoptosis of tumor cells and is thus used for the treatment of malignancy. Side effects of lapatinib include anemia, which could, at least in theory, result fr...
Main Authors: | Jens Zierle, Rosi Bissinger, Jasmin Egler, Florian Lang |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2015-12-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/438583 |
Similar Items
-
Triggering of Suicidal Erythrocyte Death by Regorafenib
by: Jens Zierle, et al.
Published: (2016-01-01) -
Triggering of Suicidal Erythrocyte Death by Pazopanib
by: Elena Signoretto, et al.
Published: (2016-03-01) -
Mitoxantrone-Induced Suicidal Erythrocyte Death
by: Markus Arnold, et al.
Published: (2014-11-01) -
Licochalcone A Induced Suicidal Death of Human Erythrocytes
by: Jasmin Egler, et al.
Published: (2015-11-01) -
Stimulating Effect of Manumycin A on Suicidal Erythrocyte Death
by: Jasmin Egler, et al.
Published: (2016-03-01)